FDA Study Calls for More Aggressive Opioid Regulation — Pain News Network

By Pat Anson, Editor

A new report commissioned by the U.S. Food and Drug Administration is calling for a sustained and coordinated national campaign to combat the opioid crisis, including more aggressive regulation of opioids by the FDA and a “cultural change” in the prescribing of opioid medication,

The report by a special committee of the National Academies of Sciences, Engineering, and Medicine(NASEM) focuses primarily on restricting the supply of prescription opioids, not illicit opioids such as heroin and fentanyl, which are now driving the so-called opioid epidemic.

“The broad reach of the epidemic has blurred the formerly distinct social boundary between prescribed opioids and illegally manufactured ones, such as heroin,” said committee chair Richard Bonnie, a Professor of Medicine and Law at the University of Virginia.

“This report provides an action plan directed particularly at the health professions and government agencies responsible for regulating them. This plan aims to help the millions of people who suffer from chronic pain while reducing unnecessary opioid prescribing. We also wanted to convey a clear message about the magnitude of the challenge. This epidemic took nearly two decades to develop, and it will take years to unravel.”

The report estimates that at least 2 million people in the U.S. have an “opioid use disorder” involving prescription opioids — meaning they are addicted to prescription painkillers — and almost 600,000 have an opioid use disorder involving heroin.

Although opioid prescribing has been declining for several years and the number of overdose deaths from prescription opioids has remained relatively stable in recent years, deaths from illicit opioids such as heroin have tripled in the past decade.

Read the full article

 

Source: FDA Study Calls for More Aggressive Opioid Regulation — Pain News Network

Personal Commentary: “This plan aims to help the millions of people who suffer from chronic pain while reducing unnecessary opioid prescribing.”

How can it help the millions of people who suffer from chronic pain if opioid prescribing is reduced or denied for said chronic pain sufferers? Who chooses which patients receive or are rejected? The physician or the government?

“The report claimed that many people who normally would use prescription opioids have transitioned to heroin because of the declining price of heroin and the introduction of abuse-deterrent formulations that make opioid medication harder to snort or inject.”

Yet the report declines to mention the many people who have never transitioned to heroin or any other type of illicit drugs.

These reports never mention the vast majority of patients who remain compliant, who’ve never failed a scheduled or random drug screen, who’s quality of life however slight was a quality enough to stay alive for.

Perhaps it’s the people who aren’t in the chronic pain they claim to be that are abusing the system and heading for heroin and perhaps it’s easier to lump us all together for political gain and ulterior motives that have little to do with helping us and everything to do with you. Just you. 

Advertisements

Action Alert: Physicians for Responsible Opioid Prescribing (PROP) We must stop this Petition!

October 11, 2012
Greetings!The RSDSA would like to make you aware of a petition currently before the Food and Drug Administration (FDA) that requests labeling changes for opioid analgesics (narcotic pain medications). Since many individuals with CRPS rely on opioids as part of their medication regimen, we wanted to bring this petition to your attention.

The petition, submitted by Physicians for Responsible Opioid Prescribing (PROP), requests three specific changes to opioid analgesic labels:

1- That they no longer be prescribed for “moderate” noncancer pain, but only for “severe” noncancer pain

2- That the maximum allowable dosage per day be equivalent to 100 mg of morphine for noncancer pain

3- That this medication can only be used for a maximum duration of 90 DAYS.

What this petition appears to mandate is a “one size fits all” prescribing mentality which DOES NOT benefit the chronic pain patients in general and CRPS patients in particular.

The RSDSA has chosen to oppose the PROP petition on behalf of you, our members. On Wednesday, October 10th, The RSDSA sent this opposition letter to the FDA.  Cick Here to read RSDSA letter . 

For those of you who would like to send your own individual response regarding PROP to the FDA, we encourage you to stress the specific details that your medication enables you to do that without it you would be unable to do. We suggest you use the following language to keep the message clear: My name is  _______. As a person  who suffers with the chronic and  yet incurable pain of  CRPS,  I ask the FDA to deny the PROP petition. I use opioids as prescribed by my physician allowing me to function better and partake in life in ways I would be unable to do without this prescribed care.

To send your comments to the FDA click here.
The category to use for your response is Individual Consumer.

Your immediate action to this issue will make a difference. To read the PROP petition,
Please forward this email along to your friends and loved ones.
Should you have any questions or would like to receive further information, please email or give me a call.
Sincerely,
JB Signature
Jim Broatch
Executive Vice President and Director
RSDSA
877-662-7737
203-877-3790
 Original Article- http://myemail.constantcontact.com/Urgent-Action-Requested–CRPS-Treatment.html?soid=1101383336163&aid=UTz5u591sNA